MAXHEALTHNSEMax Healthcare Institute LimitedLowNeutral
Announced Tue, 26 May · 23:07 IST

Max Healthcare Institute Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin ImprovementAnalyst Day Multiyear TargetsInvestor Communications View source PDF

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.8%1-day move
₹993.00
prior close
₹995.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.3-0.4-0.6-2.8-5.0-4.1-2.8-2.5+1.3+10.0+15.8+12.5
Up moveDown movePending
AI summary

Max Healthcare is India's second largest hospital chain with 6,000+ beds across 21 facilities, primarily in metro cities (73% of beds). The company reported FY26 net revenue of ₹10,065 crore (up 16% YoY) with operating EBITDA of ₹2,638 crore at 26.2% margin and PAT of ₹1,631 crore (up 22% YoY). The company has demonstrated strong historical growth with 5-year EBITDA CAGR of 33% and revenue CAGR of 22%. Management is pursuing a multi-pronged growth strategy including brownfield expansion adding ~2,000 beds, asset-light built-to-suit models, M&A opportunities, and capital-light adjacencies like Max Lab pathology and Max@Home homecare services. The company has visibility to add 8,400+ beds over coming years, with ~4,000 beds expected in the next 3-4 years at an estimated capex outflow of ₹6,672 crore.

Likely market impact

The presentation reinforces Max Healthcare's position as a quality healthcare operator with proven acquisition integration capabilities, strong cash generation (₹1,541 crore in FY26 operating cash flow), and a disciplined ROCE-focused expansion strategy. The company's metro-centric presence and high proportion of quaternary care services should support continued ARPOB improvement and margin expansion as new capacity gets absorbed.